The current research & development by business enterprise, pharmaceutical industry in constant ppp $ in the Netherlands is 354.06 million, which has increased by 0.93 million (0.3%) since 2020.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in the Netherlands
No matching regions
Similar regions to the Netherlands
Business R&D pharmaceutical in constant PPP $
More indicators for the Netherlands
Government R&D in security as % of government support
2.6%
+1%
(2021)
Higher-education-finacing R&D financed by general university in local currency
14,230.55M
-517.31M
(1998)
R&D financed by rest of the world in local currency
20,403.43M
+1,253.43M
(2021)
Government R&D financed by rest of the world in local currency
1,114.90M
-165.10M
(2021)
Business R&D financed by rest of the world in local currency
14,598.52M
+1,358.52M
(2021)
Non-profit R&D growth rate
-15.42%
-18.68%
(2002)
Netherlands Business R&D pharmaceutical in constant PPP $ between 2013 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 354.06M | +0.93M |
| 2020 | 353.13M | +49.54M |
| 2019 | 303.59M | +0.27M |
| 2018 | 303.32M | -41.38M |
| 2017 | 344.69M | +33.75M |
| 2016 | 310.94M | -21.17M |
| 2015 | 332.11M | +2.41M |
| 2014 | 329.70M | -29.52M |
| 2013 | 359.22M |